| abstract |
The pharmaceutical composition according to the present invention comprises adenine, carnitine, and cyanocobalamin, and provides a pharmaceutical composition capable of securing the stability of adenine using a blocking agent or a blocking structure, and a method for producing the same. The pharmaceutical composition according to the present invention ensures the stability of adenine, and the adenine content is maintained at 95% or more after 6 months in the stability test under the accelerated condition (40 ± 2 ° C./75 ± 5% RH). |